NMRC Begins Phase 1 Testing of Diarrhea Vaccine
SILVER SPRING, Md. (Dec. 07, 2022) – Dr. Frederic Poly and Dr. Renee Laird, research scientists with Naval Medical Research Center (NMRC), pose for a photo in the Enteric Diseases laboratory. NMRC’s Enteric Diseases Department, led by Poly, have partnered with the National Institute of Health’s National Institute of Allergy and Infectious Diseases to begin phase 1 testing of a new vaccine for Campylobacter jejuni, a foodborne pathogen. Campylobacter is one of the most common causes of diarrheal illness in the U.S. and abroad, and can impact the readiness of deployed or traveling service members. NMRC is engaged in a broad spectrum of activity from basic science in the laboratory to field studies in austere and remote areas of the world to investigations in operational environments. In support of the Navy, Marine Corps, and joint U.S. warfighters, researchers study infectious diseases, biological warfare detection and defense, combat casualty care, environmental health concerns, aerospace and undersea medicine, medical modeling, simulation, operational mission support, epidemiology, and behavioral sciences. (U.S. Navy photo by Michael Wilson/Released)
